InvestorsHub Logo
Followers 11
Posts 1099
Boards Moderated 0
Alias Born 02/20/2015

Re: elichen post# 293426

Thursday, 07/05/2018 8:17:22 PM

Thursday, July 05, 2018 8:17:22 PM

Post# of 408808
No. It's completely different. Both were part of the latest pilot study.

Is the "Unique Novel new ADF platform” what Sequest-ox new formulation is using?



We have already filed for a patent for the new non-pharmacological platform.

We recently filed a patent for platform technology for ADF product that is not pharmacologically based.




As of the most recent CC, we had not filed for a patent onSequest modification, but we probably have filed by now.

. We resolve that issue and our patent attorney, Dr. Smith determined that this is something patentable and we will be filing a patent sometime next week.



https://seekingalpha.com/article/4182056-elite-pharmaceuticals-inc-eltp-ceo-nasrat-hakim-q4-2018-results-earnings-call-transcript?part=single
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News